Qualitative analysis of Indonesian hospital pharmacist’s perceptions of their roles and behaviour during the covid-19 pandemic

Dina Ayu Prasetyaningrum; Tunggul Adi Purwonugroho; Ika Mustikaningtia; Dewi Latifatul Ilma; Nia Kurnia Sholihat; Laksmi Maharani

doi:10.22146/ahj.v6i2.100052

Qualitative analysis of Indonesian hospital pharmacist’s perceptions of their roles and behaviour during the covid-19 pandemic

https://doi.org/10.22146/ahj.v6i2.100052

Dina Ayu Prasetyaningrum^(1*), Tunggul Adi Purwonugroho⁽²⁾, Ika Mustikaningtia⁽³⁾, Dewi Latifatul Ilma⁽⁴⁾, Nia Kurnia Sholihat⁽⁵⁾, Laksmi Maharani⁽⁶⁾

(1) Department of Pharmacy, Faculty of Health Sciences, University of Jenderal Soedirman, Purwokerto
(2) Department of Pharmacy, Faculty of Health Sciences, University of Jenderal Soedirman, Purwokerto
(3) Department of Pharmacy, Faculty of Health Sciences, University of Jenderal Soedirman, Purwokerto
(4) Department of Pharmacy, Faculty of Health Sciences, University of Jenderal Soedirman, Purwokerto
(5) Department of Pharmacy, Faculty of Health Sciences, University of Jenderal Soedirman, Purwokerto
(6) Department of Pharmacy, Faculty of Health Sciences, University of Jenderal Soedirman, Purwokerto
(*) Corresponding Author

Abstract

Background: Pharmacists are health workers who play an important role in dealing with COVID-19 pandemic problems. This study explored the hospital pharmacist's perception of their roles and behaviours and the influence factors during the COVID-19 pandemic period.

Material and Methods: The research was conducted using phenomenological qualitative methods through in-depth online interviews using an online meetings platform. Informants were taken until the data was saturated. Credibility tests by member checking, dependability, and confirmability tests were performed to ensure data validity. The results of the interviews then were analyzed by thematic analysis.

Results: Eight informants were included with 5 emerging themes revealed from this study. The theme consists of the pharmacist's high commitment to his important role as a team member of the healthcare provider in providing the best service by adapting their services, ensuring rational therapy for COVID-19 patients, and maintaining the availability of medicines, medical devices, and consumable medical materials. Furthermore, pharmacists described some innovation strategies, like drug delivery for outpatients and telepharmacy services. The supporting factors for pharmacists in their services were interprofessional collaboration between pharmacists and other healthcare providers. Support from colleagues, hospital management, government, donations and technology were also revealed as positive factors. The barrier factors included uncertain pandemic conditions, pharmacists who were exposed to the virus and the mental health condition of healthcare professionals during the pandemic.

Conclusion: Pharmacists have a strong commitment to playing a crucial part in the healthcare team in offering the most treatment possible and providing management work. They created some innovative initiatives to tackle the COVID-19 burden. Supportive and barrier factors that affect pharmacist performance during pandemics were also disclosed and examined in this paper.

Keywords:

Keywords

pharmacists; hospital; COVID-19; qualitative; perception

Full Text:

PDF

References

Cheong MWL. "To be or not to be in the ward": The impact of COVID-19 on the role of hospital-based clinical pharmacists-A qualitative study. J Am Coll Clin Pharm 2020;3(8):1458-1463. 2. Li H, Zheng S, Liu F, Liu W, Zhao R. Fighting against COVID-19: Innovative strategies for clinical pharmacists. Res Social Adm Pharm 2021;17(1):1813-1818. 3. Danelich IM, Thomson L, Alberto J, Bonanni S, Buckler R, Foley J, et al. Adaptation of clinical pharmacy services to meet patient care needs during the COVID-19 pandemic. J Am Coll Clin Pharm 2021;4(3):364-371. 4. Watson KE, Schindel TJ, Barsoum ME, Kung JY. COVID the Catalyst for Evolving Professional Role Identity? A Scoping Review of Global Pharmacists' Roles and Services as a Response to the COVID-19 Pandemic. Pharmacy (Basel) 2021;9(2). 5. Paudyal V, Cadogan C, Fialová D, Henman MC, Hazen A, Okuyan B, et al. Provision of clinical pharmacy services during the COVID-19 pandemic: Experiences of pharmacists from 16 European countries. Res Social Adm Pharm 2021;17(8):1507-1517. 6. Al-Quteimat Om Msc B, Amer Am Rph M. SARS-CoV-2 outbreak: How can pharmacists help? Res Social Adm Pharm 2021;17(2):480-482. 7. Thong KS, Selvaratanam M, Tan CP, Cheah MF, Oh HL, Lee PM, et al. Pharmacy preparedness in handling COVID-19 pandemic: a sharing experience from a Malaysian tertiary hospital. Journal of Pharmaceutical Policy and Practice 2021;14(1):61. 8. Bragazzi NL, Mansour M, Bonsignore A, Ciliberti R. The Role of Hospital and Community Pharmacists in the Management of COVID-19: Towards an Expanded Definition of the Roles, Responsibilities, and Duties of the Pharmacist. Pharmacy (Basel) 2020;8(3). 9. Ying W, Qian Y, Kun Z. Drugs supply and pharmaceutical care management practices at a designated hospital during the COVID-19 epidemic. Res Social Adm Pharm 2021;17(1):1978-1983. 10. Zeenny RM, Ramia E, Akiki Y, Hallit S, Salameh P. Assessing knowledge, attitude, practice, and preparedness of hospital pharmacists in Lebanon towards COVID-19 pandemic: a cross-sectional study. Journal of Pharmaceutical Policy and Practice 2020;13(1):54. 11. Chen Q, Liang M, Li Y, Guo J, Fei D, Wang L, et al. Mental health care for medical staff in China during the COVID-19 outbreak. Lancet Psychiatry 2020;7(4):e15-e16. 12. Gross AE, MacDougall C. Roles of the clinical pharmacist during the COVID-19 pandemic. JACCP: JOURNAL OF THE AMERICAN COLLEGE OF CLINICAL PHARMACY 2020;3(3):564-566. 13. Giannis D, Geropoulos G, Matenoglou E, Moris D. Impact of coronavirus disease 2019 on healthcare workers: beyond the risk of exposure. Postgrad Med J 2021;97(1147):326-328. 14. Segal EM, Alwan L, Pitney C, Taketa C, Indorf A, Held L, et al. Establishing clinical pharmacist telehealth services during the COVID-19 pandemic. Am J Health Syst Pharm 2020;77(17):1403-1408.

DOI: https://doi.org/10.22146/ahj.v6i2.100052